FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35813111000001107: Roflumilast 250microgram tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
109955701000001113 Roflumilast 250microgram tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109955801000001116 Roflumilast 250microgram tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Roflumilast 250microgram tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Is a Roflumilast true Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Is a Product containing roflumilast false Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Has active ingredient Roflumilast false Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Has specific active ingredient Roflumilast true Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Daxas 250microgram tablets (AstraZeneca UK Ltd) Is a True Roflumilast 250microgram tablets Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets 28 tablet Has VMP True Roflumilast 250microgram tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start